Aziz Mehar, Chaurasia Jai Kumar, Khan Roobina, Afroz Nishat
Department of Pathology, Jawaharlal Nehru Medical College (JNMC), Aligarh Muslim University (AMU), Aligarh, Uttar Pradesh, India.
BMJ Case Rep. 2014 Apr 12;2014:bcr2013202051. doi: 10.1136/bcr-2013-202051.
A 45-year-old Indian woman presented in neurosurgery outpatient with seizures, headache and vomiting for the past 1 month. MRI of the brain was suggestive of a malignant central nervous system (CNS) tumour. Histological and immunohistochemical examinations of stereotactic biopsy of the tumour were diagnostic of a low-grade diffuse small lymphocytic lymphoma of the CNS. No evidence of any occult systemic lymphoma was observed, confirming its 'primary' origin in the CNS. The diagnosis of a low-grade primary CNS lymphoma (PCNSL) is difficult as clinical and neuroradiological features are wide and variable. The clinical course is more indolent than a high-grade PCNSL and thus, a less aggressive and localised targeted treatment could be sufficient rather than the high dose, neurotoxic methotrexate-based chemotherapeutic treatment, recommended for high-grade PCNSL. Histological and immunohistological confirmation is therefore mandatory for early, appropriate treatment and prognostic implications.
一名45岁的印度女性因过去1个月出现癫痫发作、头痛和呕吐症状,前往神经外科门诊就诊。脑部磁共振成像(MRI)提示为恶性中枢神经系统(CNS)肿瘤。对该肿瘤进行立体定向活检的组织学和免疫组织化学检查,诊断为中枢神经系统低度弥漫性小淋巴细胞淋巴瘤。未观察到隐匿性系统性淋巴瘤的证据,证实其起源于中枢神经系统的“原发性”。由于临床和神经放射学特征广泛且多变,低度原发性中枢神经系统淋巴瘤(PCNSL)的诊断较为困难。其临床病程比高度PCNSL更为惰性,因此,对于低度PCNSL,采用侵袭性较小的局部靶向治疗可能就足够了,而不是像高度PCNSL那样采用基于高剂量、具有神经毒性的甲氨蝶呤的化疗方案。因此,组织学和免疫组织学确诊对于早期、恰当的治疗及预后判断至关重要。